Tenor Capital Management’s enGene Therapeutics Warrants ENGNW Stock Holding History

Tenor Capital Management’s Portfolio ENGNW Stock Details ENGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$140K	Hold	55,243	–	–	﹤0.01%	335
2025 Q4	$164K	Hold	55,243	–	–	﹤0.01%	307
2025 Q3	$39.2K	Hold	55,243	–	–	﹤0.01%	318
2025 Q2	$45.3K	Hold	55,243	–	–	﹤0.01%	280
2025 Q1	$33.2K	Hold	55,243	–	–	﹤0.01%	216
2024 Q4	$46.6K	Hold	55,243	–	–	﹤0.01%	188
2024 Q3	$116K	Hold	55,243	–	–	﹤0.01%	162
2024 Q2	$65.7K	Sell	55,243 -9,757	-15%	-$31.2K	﹤0.01%	169
2024 Q1	$338K	Sell	65,000 -51,666	-44%	-$157K	0.01%	177
2023 Q4	$99.2K	Buy	+116,666	New	+$89.7K	﹤0.01%	178

Other funds holding ENGNW

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return

CSS LLC Chicago, Illinois $1.8B AUM 59.56% 1-Year Est. Return

Ionic Capital Management New York $119M AUM 48.26% 1-Year Est. Return

Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return